Dr. Blake Byers serves as General Partner at GV. He serves as the Interim President and Board Member at Lime and Pact Pharma. He continues to direct research at Stanford University in optogenetics and stem cell biology. He began doing biomedical research at Stanford as a high school student and has continued to conduct research since then - with topics spanning antibiotic mechanisms of action, Parkinson's disease modeling, and fMRI imaging of xenogeneic brain grafts. Outside of the lab, he has worked at Electronic Arts, Morgan Stanley, and as an angel investor. He received a Ph.D. and master's in bioengineering from Stanford University and holds a Bachelor of Science in biomedical engineering and Bachelor of Science in economics from Duke University. He serves as a Board Member at Ionq. He served as Board Member at MediaSpike. He serve as Board Member at Magenta Therapeutics and Robinhood & as Board Observer at Obsidian Therapeutics. He previously served as Board Member at Transcriptic.